Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
QNCX Quince Therapeutics
0.920-0.060-6.12%
Trading Session
02/01 14:57 ET
High
0.979
Open
0.979
Turnover
418.08K
Low
0.900
Pre Close
0.980
Volume
447.94K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Quince Therapeutics Sees FY23 Annual Capital, Operating Expenditures ~$11M
Quince Therapeutics Sees FY23 Annual Capital, Operating Expenditures ~$11M
Quince Therapeutics Provides Pipeline Update and Business Outlook for 2023
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--$QNCX--Quince Therapeutics, Inc. (Nasdaq: QNCX), a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics tha
G Medical, Sharps Top Healthcare Gainers; Quince, Icosavax Among Losers
Alibaba Group, Bilibili, Lufax Holding Among Premarket Losers' Pack
Why CN Energy Group Shares Are Trading Lower By 47%; Here Are 20 Stocks Moving Premarket
Gainers BigBear.ai Holdings, Inc. (NYSE:BBAI) shares rose 45.4% to $3.52 in pre-market trading after gaining around 7% on Friday. BigBear.AI recently announced a $25 million private placement.Freight
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersG Medical Innovations (NASDAQ:GMVD) stock moved upwards by 98.7% to $5.96 during Monday's pre-market session. The market value of their outstanding shares is at $8.4 million. Aethlon Medical (N
Why Applied UV Shares Are Trading Higher By 46%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers FOXO Technologies Inc. (NYSE:FOXO) shares jumped 109% to $1.07.Akanda Corp. (NASDAQ:AKAN) rose 59% to $0.4459 after jumping 47% on Thursday.Applied UV, Inc. (NASDAQ:AUVI) gained 46.1% to $1.52
Quince Hits Three Month High on Sale of Protease Inhibitors
12 Health Care Stocks Moving In Friday's Intraday Session
GainersAkanda (NASDAQ:AKAN) stock moved upwards by 50.0% to $0.42 during Friday's regular session. Trading volume for Akanda's stock is 79.7 million as of 12:30 EST. This is 2715.6% of its average ful
Nasdaq Jumps 100 Points; Crude Oil Down 1%
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Friday. The Dow traded up 0.29% to 34,047.95 while the NASDAQ rose 0.88% to 11,613.37. The S&P
Company Overview
More
Quince Therapeutics, Inc.(formerly Cortexyme, Inc.） is a biopharmaceutical company, which engages in the development and commercialization of therapeutics. Its pipeline composed of COR388, COR588, COR788, COR822, and Coronavirus 3CL protease inhibitor. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.
CEO： Mr. Dirk Thye
Market： NASDAQ
Listing Date： 05/09/2019
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet